The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma

British Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 469-475

  Iizuka, N ^a   Hirose, K ^b   Noma, T ^a   Hazama, S ^a   Tangoku, A ^a   Hayashi, H ^a   Abe, T ^a   Yamamoto, K ^a   Oka, M ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KUREHA CORPORATION   (Japan)

Author keywords

Chemotherapy; Cisplatin; nm23; Oesophageal squamous cell carcinoma; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER SURVIVAL; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; WESTERN BLOTTING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DNA, COMPLEMENTARY; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; OLIGONUCLEOTIDES, ANTISENSE; SURVIVAL ANALYSIS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TRANSFECTION; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0032883690     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690717     Document Type: Article

References (33)

1. Andrews PA and Albright KD (1992) Mitochondrial defects in cisdiamminedichloroplatinum (II)-resistant human ovarian carcinoma cells. Cancer Res 52: 1895-1901
2. Berridge MV and Tan AS (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303: 474-482
3. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier J, Pavy JJ, Mercier M and Sahmoud T (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337: 161-167
4. Caligo MA, Cipollini G, Fiorc L, Calvo S, Basolo F, Collecchi P, Ciardiello F, Pepe S, Petrini M and Bevilacqua G (1995) NM23 gene expression correlates with cell growth rate and S-phase. Int J Cancer 60: 837-842
5. Cox DR (1972) Regression models and life table. J R Stat Soc 34: 187-220
6. de Geovani C, Landuzzi L, Frabetti F, Nicoletti G, Griffoni C, Rossi I, Mazzotti M, Scotto L, Nanni P and Lollini PL (1996) Antisensc epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells. Cancer Res 56: 3898-3901
7. Easty DJ, Maung K, Lascu I, Veron M, Fallowfield ME, Hart IR and Bennett DC (1996) Expression of NM23 in human melanoma progression and metastasis. Br J Cancer 74: 109-114
8. Ferguson AW, Flatow U, MacDonald NJ, Larminat F, Bohr VA and Steeg PS (1996) Increased sensitivity to cisplatin by nm23-transfected tumor cell lines. Cancer Res 56: 2931-2935
9. Florenes VA, Aamdal S, Myklebost O, Maclandsmo GM, Bruland OS and Fodstad O (1992) Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res 52: 6088-6091
10. Freije JM, Lawrence JA, Hollingshead MG, De la Rosa A, Narayanan V, Grever M, Sausville EA, Paull K and Steeg PS (1997) Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines. Nat Med 4: 395-401
11. Gauthier T, Denis-Pouxviel C and Murat JC (1990) Respiration of mitochondria isolated from differentiated and undifferentiated HT29 colon cancer cells in the presence of various substrates and ADP generating systems. Int J Biochem 22: 411-417
12. Higashiyama M, Doi O, Yokouchi H, Kodama K, Nakamori S, Tateishi R and Kimura N (1992) Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: Lack of prognostic value. Br J Cancer 66: 533-536
13. Hishikawa Y, Abe S, Kinugasa S, Yoshimura H, Monden N, Igarashi M, Tachibana M and Nagasue N (1997) Overexpression metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer. Oncology 54: 342-347
14. Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K and Suzuki T (1995) NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res 55: 652-657
15. International Union Against Cancer. Sobin LH and Wittekind C (1997) TNM Classification of Malignant Tumors, 5th edn. pp. 54-58. Wiley-Liss Inc: New York
16. Jiang WG, Hiscox S, Bryce RP, Horrobin DF and Mansel RE (1998) The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells. Br J Cancer 77: 731-738
17. Kaplan BL and Meier P (1958) Nonparametic estimation from incomplete observations. J Am Stat Assoc 53: 457-481
18. Kok TC, Van der Gaast A, Dees J, Fykenboom WM, van Overhagen H, Stoter G, Tilanus HW and Splinter TA (1996) Cisplatin and etopside in oesophageal cancer: a phase II study. Br J Cancer 74: 980-984
19. Lindmark G (1996) NM-23 HI immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer. Br J Cancer 74: 1413-1418
20. McLeod HL, Sludden J, Murray GI, Keenan RA, Davidson AI, Park K, Koruth M and Cassidy J (1998) Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer 77: 461-465
21. Nguyen HN, Sevin BU, Averette HE, Perras J, Ramos R, Donato D, Ochiai K and Penalver M (1993) Cell cycle perturbations of platinum derivatives on two ovarian cancer cell lines. Cancer Invest 11: 264-275
22. Nita ME, Nagawa H, Tominaga O, Tsuno N, Fujii S, Sasaki S, Fu CG, Takenoue T, Tsuruo T and Muto T (1998) 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. Br J Cancer 78: 986-992
23. Oka M, Iizuka N, Yamamoto K, Gondo T, Abe T, Hazama S, Akitomi Y, Koshihara Y, Ohsugi Y, Ooba Y, Ishihara T and Suzuki T (1996) The influence of interleukin-6 on the growth of human esophageal cancer cell lines. J Interferon Cytokine Res 16: 1001-1006
24. Olivero OA, Semino C, Kassim A, Lopez-Larraza DM and Poirier MC (1995) Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary cells. Mutatíon Res 346: 221-230
25. Patel DD, Bhatavdekar JM, Chikhlikar PR, Patel YV, Shah NG, Ghosh N, Suthar TP and Balbar DB (1997) Clinical significance of p53. nm23, and bcl-2 in T3-4N1M0 ocsophageal carcinoma: an immunohistochemical approach. J Surg Oncol 65: 111-116
26. Roder JD, Busch R, Stein HJ, Fink U and Siewert JR (1994) Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 81: 410-413
27. Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M and Dmitrovsky E (1995) Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. Cancer Res 55: 5038-5042
28. Scambia G, Ferrandina G, Marone M, Benedetti PP, Giannitelli C, Piantelli M, Leone A and Mancuso S (1996) Nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters. J Clin Oncol 14: 334-342
29. Stahl M, Wilke H, Fink U, Stuschke M, Walz MK, Siewen JR, Moll M, Fett W, Makoski HB, Breuer N, Schmidt U, Niebel W, Sack H, Eigler FW and Seeber S (1996) Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol 14: 829-837
30. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JB, Liotta LA and Sobel M (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204
31. Timmer-Bosscha H, Timmer A, Meijer C, de Vries EG, de Jong B, Oosterhuis JW and Mulder NH (1993) cis-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Res 53: 5707-5713
32. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T and Shiku H (1993) Reduced expression of nm23-H1, but not of nm23-H2 is concordant with the frequency or lymph node metastasis of human breast cancer. Int J Cancer 55: 66-71
33. Yamamoto K, Oka M, Hayashi H, Tangoku A, Gondo T and Suzuki T (1997) CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 79: 1647-1655